Trends and Finance: Page 2

AbbVie to buy Landos Biopharma for up to $212M
By LabPulse.com staff writers
AbbVie has announced that it will buy drug developer Landos Biopharma in a deal worth up to $212 million. The deal will expand Abbvie’s portfolio, especially in the arena of immune system-related illnesses.
March 25, 2024
Business Graph Money Stocks Social
Protein design firm Profluent raises $35M in funding
By LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
Computer Brain Money Social
Bluebird Bio secures up to $175M in debt financing
By LabPulse.com staff writers
Bluebird Bio has secured up to $175 million in debt financing with Hercules Capital, having entered into a five-year term loan facility that provides funds in separate tranches.
March 18, 2024
Research Money Social
Siemens Healthineers to close Fast Track Diagnostics unit
By LabPulse.com staff writers
Siemens Healthineers intends to close its Fast Track Diagnostics unit by September 2024.
March 19, 2024
Business Economics Pie Chart2 Social
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
Dna Sequencing Data Analysis Social
NGeneBio, Genolution to collaborate on automated NGS system
By LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Business Handshake Intelligence Social
Zephyr AI closes $111M series A funding round
By LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
Artificial Intelligence Drug Design Funding Social
T2 Biosystems granted Nasdaq listing extension
By LabPulse.com staff writers
Nasdaq's Hearings Panel has granted T2 Biosystems' request for an extension for continued listing on the stock market subject to T2 complying with Nasdaq's rule for market value of listed securities.
March 12, 2024
Earning Stock Market Social
Patient Square Capital to acquire NanoString assets for $220M
By LabPulse.com staff writers
NanoString Technologies has reached a binding agreement with Patient Square Capital in which NanoString will sell substantially all of its assets to the investment firm for $220 million.
March 11, 2024
Business Agreement Social
Ginkgo Bioworks launches technology network
By Matt Limb
Ginkgo Bioworks has launched a new technology network with 25 partners, pledging to improve customers’ research and development outcomes.
March 6, 2024
Global Collaboration Business Social
MD Anderson Cancer Center acquires cell therapy switch technologies
By Matt Limb
The University of Texas MD Anderson Cancer Center has acquired inducible switch technologies for development in cell therapy programs from Bellicum Pharmaceuticals.
March 7, 2024
Cell Analysis Therapy Engineering Social
Eisai invests $15M in C2N to increase Alzheimer's test access
By LabPulse.com staff writers
C2N Diagnostics has announced that pharmaceutical company Eisai has agreed to invest up to $15 million in C2N to provide broader access to Alzheimer’s disease tests.
March 6, 2024
Amyloid Plaque Alzheimer2 Social
Previous Page
Page 2 of 132
Next Page